Stryker Gaining Ground in OUS Hip Replacement Market Chart of the Month The Numbers Our chart of the month looks at the ten-year sales history for OUS hip replacement among Zimmer Biomet, Stryker and DePuy Synthes. Jun 03, 2026
Volatile International Markets Bring Challenges in Early 2026 Market Analysis The Numbers Healthcare strikes, shifting market share opportunities and volume-based procurement have created a dynamic OUS market in 2026. Jun 01, 2026
The State of Trauma 2026 Videos An overview of the segment's growth, performance of its top players and new market entrants trying to build a base of business. Jun 01, 2026
Orthopedic Executives Reflect on First Quarter of 2026 Executive Insights Industry Voices Selected comments from the leaders of top orthopedic companies as they reported first quarter 2026 earnings. May 19, 2026
Shoulder Innovations’ Growth Driven by Deepening Surgeon Base Company Revenue The Numbers The company grew nearly 65% in the first quarter of 2026 due to rapid surgeon onboarding and expanding product indications. May 18, 2026
SI-BONE Progresses Toward Durable Growth Engine Company Revenue The Numbers The company grew double-digits in the first quarter of 2026 thanks to its broadening procedural footprint and expanding commercial scale. May 15, 2026
Carlsmed’s Education and Outcomes Driving Volume Growth Company Revenue The Numbers The company grew more than 50% in the first quarter of 2026 as its personalized lumbar and cervical systems gain adoption. May 15, 2026
Treace Looks to Weather Storm in 2026 as Mix Shifts Company Revenue The Numbers The company's sales declined more than 10% as its mix shifts away from Lapiplasty toward lower-cost MIS bunion systems. May 14, 2026
Smith+Nephew’s Segment Performance Shows Promising Trends Chart of the Month The Numbers Our chart of the month looks at Smith+Nephew's historical segment performance, with a focus on sports medicine and hip replacement. May 14, 2026
Globus’ Strong 1Q Brings New Approach for Technology Company Revenue The Numbers The company's base business grew 13.2% in the first quarter of 2026, driven by continued strength in spine and resurgent enabling technology. May 13, 2026